A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Peel Therapeutics Inc
- Target Recruit Count
- 42
- Registration Number
- NCT05329103
- Locations
- 🇺🇸
HonorHealth Research Institiute, Scottsdale, Arizona, United States
🇺🇸Stanford Cancer Center, Palo Alto, California, United States
🇺🇸Carolina BioOncology Institute, Huntersville, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath